Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kindgen Biotech is a specialized biotechnology company based in Wuhan, China, that focuses on the development, manufacturing, and distribution of high-end diagnostic reagents and esoteric testing kits. As a core subsidiary of Kindstar Global, the company provides the technical foundation for advanced clinical testing services across a wide range of medical specialties. Their product portfolio emphasizes precision medicine, utilizing technologies such as next-generation sequencing (NGS), flow cytometry, and polymerase chain reaction (PCR). The company's primary therapeutic focus areas include hematology, oncology, infectious diseases, and rare genetic disorders. Kindgen Biotech operates state-of-the-art facilities that support the large-scale production of reagents used by thousands of hospitals throughout China. By integrating research and development with manufacturing, the company ensures the rapid translation of genomic and proteomic discoveries into clinical diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Kindgen Biotech.